Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion

NCT03197194 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03197194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03197194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Completed
Start date
June 8, 2018
Completion date
January 16, 2024
Enrollment
70 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal artery occlusion